Mikhaël Attias

Statistics

Publications

Citations

140

H-Index

Active since

2015

Affiliations

McGill University Health Centre(Current)

McGill University

Mikhaël Attias is an author at McGill University Health Centre specializing in immune checkpoint inhibitors, oncology, and checkpoint inhibitor therapy.

ORCID

Publications per year

2015–2024

Publications

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses

Fan Huang, Christophe Gonçalves, Margarita Bartish et al. · Journal of Clinical Investigation · 2021 · 65 citations · Full text

Medicine, Immunology, Oncology +17

Materno-Fetal Transfer of Preproinsulin Through the Neonatal Fc Receptor Prevents Autoimmune Diabetes

Slobodan Čulina, Nimesh Gupta, Raphaël Boisgard et al. · Diabetes · 2015 · 27 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma

Ali Mehdi, Mikhaël Attias, Niaz Mahmood et al. · Frontiers in Oncology · 2020 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone

Ali Mehdi, Mikhaël Attias, Ani Arakelian et al. · Cancers · 2022 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

The impact of Foxp3 <sup>+</sup> regulatory T‐cells on CD8 <sup>+</sup> T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

Mikhaël Attias, Ciriaco A. Piccirillo · British Journal of Pharmacology · 2024 · 14 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 5